JOHN CHANCELLOR

Concepts (11)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with JOHN CHANCELLOR's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that JOHN CHANCELLOR has written about over time.
Cell- and Tissue-Based Therapy, 1 publications between 2024 and 2024, average publication date December 2024. Diabetes Mellitus, Type 2, 1 publications between 2024 and 2024, average publication date December 2024. Diabetic Retinopathy, 1 publications between 2024 and 2024, average publication date December 2024. Genetic Therapy, 1 publications between 2024 and 2024, average publication date December 2024. Glucagon-Like Peptide-1 Receptor, 1 publications between 2024 and 2024, average publication date December 2024. Glucagon-Like Peptides, 1 publications between 2024 and 2024, average publication date December 2024. Humans, 2 publications between 2024 and 2024, average publication date December 2024. Hypoglycemic Agents, 1 publications between 2024 and 2024, average publication date December 2024. Neuroprotective Agents, 1 publications between 2024 and 2024, average publication date December 2024. Optogenetics, 1 publications between 2024 and 2024, average publication date December 2024. Retinitis Pigmentosa, 1 publications between 2024 and 2024, average publication date December 2024.

To see the data from this visualization as text, click here.
CHANCELLOR's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (11)
Explore
_
Co-Authors (2)
Explore
_
Same Department Expand Description
Explore
_